Company intelligence / Profile preview

RadiRad

New Taipei City, Taiwanradirad.com ↗

Ownership: Private
Development stage: Commercial

Overview

RadiRad has developed and commercialized advanced AI-driven solutions to assist physicians with rapid, accurate diagnosis based on medical imaging and physiological data. Their flagship product, RadiSpine, automates MRI spine image segmentation to improve the accuracy of spinal disorder diagnoses. The company emphasizes workflow efficiency, quantitative assessment, and integration with hospital systems. Clinical results are focused on improved diagnostic precision rather than therapeutic outcomes.

Therapeutic areas: OtherNeurology
Modalities: DeviceSoftware (AI-powered diagnostic tool)
Industry: Digital Health Medical Devices

Beyond the preview

Go deeper on RadiRad.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on RadiRad.

Explore the full profile